Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels

• Shinya Okamoto,

  Affiliation Department of Biochemistry, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan

  ⨯
• Yuanyuan Jiang,

  Affiliations Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan, Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Kiyoko Kawamura,

  Affiliation Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan

  ⨯
• Masato Shingyoji,

  Affiliation Department of Thoracic Disease, Chiba Cancer Center, Chiba, Japan

  ⨯
• Toshihiko Fukamachi,

  Affiliation Department of Biochemistry, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan

  ⨯
• Yuji Tada,

  Affiliation Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Yuichi Takiguchi,

  Affiliation Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Koichiro Tatsumi,

  Affiliation Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Hideaki Shimada,

  Affiliation Department of Surgery, School of Medicine, Toho University, Tokyo, Japan

  ⨯
• Kenzo Hiroshima,

  Affiliation Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan

  ⨯
• Hiroshi Kobayashi,

  Affiliation Department of Biochemistry, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan

  ⨯
• Masatoshi Tagawa

  * E-mail: mtagawa@chiba-cc.jp

  Affiliations Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan, Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯